Sage Rhino Capital’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $407K | Sell |
8,419
-229
| -3% | -$11.1K | 0.09% | 147 |
|
2025
Q1 | $480K | Buy |
8,648
+26
| +0.3% | +$1.44K | 0.11% | 139 |
|
2024
Q4 | $416K | Buy |
8,622
+47
| +0.5% | +$2.27K | 0.09% | 147 |
|
2024
Q3 | $494K | Buy |
8,575
+149
| +2% | +$8.59K | 0.11% | 137 |
|
2024
Q2 | $409K | Buy |
8,426
+59
| +0.7% | +$2.86K | 0.1% | 142 |
|
2024
Q1 | $407K | Buy |
8,367
+161
| +2% | +$7.83K | 0.1% | 145 |
|
2023
Q4 | $408K | Sell |
8,206
-516
| -6% | -$25.7K | 0.1% | 136 |
|
2023
Q3 | $468K | Buy |
8,722
+240
| +3% | +$12.9K | 0.13% | 121 |
|
2023
Q2 | $457K | Sell |
8,482
-87
| -1% | -$4.69K | 0.13% | 124 |
|
2023
Q1 | $466K | Buy |
8,569
+647
| +8% | +$35.2K | 0.14% | 120 |
|
2022
Q4 | $384K | Buy |
7,922
+830
| +12% | +$40.2K | 0.12% | 131 |
|
2022
Q3 | $270K | Sell |
7,092
-616
| -8% | -$23.5K | 0.11% | 142 |
|
2022
Q2 | $386K | Buy |
7,708
+207
| +3% | +$10.4K | 0.15% | 114 |
|
2022
Q1 | $385K | Buy |
7,501
+3
| +0% | +$154 | 0.12% | 145 |
|
2021
Q4 | $376K | Sell |
7,498
-58
| -0.8% | -$2.91K | 0.11% | 139 |
|
2021
Q3 | $364K | Buy |
7,556
+374
| +5% | +$18K | 0.11% | 131 |
|
2021
Q2 | $378K | Buy |
7,182
+611
| +9% | +$32.2K | 0.11% | 135 |
|
2021
Q1 | $325K | Buy |
6,571
+61
| +0.9% | +$3.02K | 0.11% | 131 |
|
2020
Q4 | $316K | Buy |
6,510
+135
| +2% | +$6.55K | 0.12% | 121 |
|
2020
Q3 | $320K | Hold |
6,375
| – | – | 0.15% | 108 |
|
2020
Q2 | $325K | Buy |
6,375
+27
| +0.4% | +$1.38K | 0.17% | 105 |
|
2020
Q1 | $278K | Buy |
6,348
+331
| +6% | +$14.5K | 0.2% | 95 |
|
2019
Q4 | $311K | Buy |
6,017
+409
| +7% | +$21.1K | 0.18% | 112 |
|
2019
Q3 | $260K | Buy |
5,608
+243
| +5% | +$11.3K | 0.16% | 111 |
|
2019
Q2 | $232K | Buy |
5,365
+360
| +7% | +$15.6K | 0.15% | 116 |
|
2019
Q1 | $222K | Buy |
+5,005
| New | +$222K | 0.15% | 115 |
|